HEAT telemedicine program for HIV and addiction care
Official title: HIV, Equity, and Addiction Training (HEAT) Program
Run by University of Alabama at Birmingham · NCT06370481 · Data updated 2026-11-12
This project will try a telemedicine program to deliver addiction treatment to adults living with HIV in Alabama who report opioid or stimulant misuse.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 30 (estimated) |
| Sponsor | University of Alabama at Birmingham Academic / other |
| Locations | 1 site (Birmingham, Alabama) |
| Status | Recruiting |
| Started | January 29, 2026 |
| Main results expected | December 2028 |
| Study ends | June 2029 |
| Registry record updated | February 18, 2026 |
| Trial ID | NCT06370481 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults (18+) living with HIV who receive care at participating Alabama HIV clinics and report opioid or stimulant misuse are the intended participants.
✕Probably not a fit
People currently receiving SUD care outside their HIV clinic, those who are psychotic, actively suicidal, or who cannot participate independently in telemedicine interviews are unlikely to benefit from this program.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This pilot tests whether a telemedicine service can feasibly and acceptably deliver substance use disorder care to people living with HIV in Alabama. Participants are adults receiving services at HIV clinics who report opioid or stimulant misuse and will be offered telemedicine-based addiction care alongside standard clinic services. The study will collect patient and provider feedback, measures of engagement and linkage to SUD treatment, and feasibility metrics. Results will inform whether telemedicine can reduce access barriers in rural and under-resourced parts of the Deep South.
Why it matters
Potential benefit: If successful, the program could expand timely access to addiction treatment and better connect HIV care with SUD services for people in underserved areas.
How similar studies have gone: Telemedicine has shown promise for addiction and HIV services in other settings, but few studies have tested such programs in the Deep South, so evidence in this specific population is limited.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Receiving services at HIV clinics in Alabama * Reported opioid and/or stimulant misuse * 18 years of age or older Exclusion Criteria: * Receipt of SUD clinical care other than through HIV provider/clinic in the last 3 months * Inability to engage in interviews independently without support (e.g., cognitive impairment) * Currently psychotic * Actively suicidal: presents with a suicide attempt or suicidal ideation
Where it's running
-
University of Alabama at Birmingham
Birmingham, Alabama, United States Recruiting
Study contacts
- Principal investigator: Ellen F Eaton, MD, MSPH — University of Alabama at Birmingham
- Study coordinator: Ellen F Eaton, MD, MSPH
- Email: eeaton@uabmc.edu
- Phone: 2059750661
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Impact of MOUD Policy Changes During the Pandemic on Opioid and Alcohol Use Disorders
This study tests how federal and state policy changes during the COVID-19 pandemic affected access to and use of medications for opioid use disorder among Veterans with opioid or alcohol use disorders.
-
Collaborative care program for young Black and Latino men at risk for HIV
This study tests a new support program to help young Black and Latino men at risk for HIV start taking prevention medication and manage their substance use better.
-
Engagement of community health workers to support recovery from substance use disorders
This study is testing whether support from community health workers can help people with substance use disorders engage better in treatment and improve their recovery experience after visiting the emergency department.
-
Helping MSM with HIV and substance use disorders overcome stigma and shame
This study is testing a new program to help men who have sex with men and gender minorities living with HIV and substance use issues feel better about themselves and manage their health by reducing stigma and shame.
-
Improving HIV prevention for people who inject drugs on PrEP
This study is testing new ways to help people who inject drugs and are on HIV prevention medication to better understand and use information about staying safe from HIV.
-
Innovative e-Health interventions for HIV and substance use in women involved in the justice system
This study is testing a new online tool to help women in the justice system access HIV prevention and opioid treatment more easily, comparing it to a simpler version of the tool.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.